ResMed CEO sells 3,200 shares

Thursday, June 19, 2014

NEW YORK – ResMed CEO Michael Farrell sold 3,200 shares of company stock on the open market June 16. Farrell sold the shares at an average price of $53.20 for a total of $170,240. He now directly owns 106,655 shares valued at approximately $5.7 million. On Wednesday, June 18, ResMed traded up 0.70% at $53.06, reports say. Farrell is one of a number of execs at the company who has sold shares in May and June.